Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can fish oils calm endometriosis inflammation?

NCT ID NCT07800442

Disease control Sponsor: Angelika Bogusz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This trial tests whether a daily fish-derived lipid supplement, taken for 12 weeks alongside standard dietary advice, can reduce inflammation and pain in women with endometriosis. Researchers will randomly assign 46 women aged 18 to 55 with a confirmed diagnosis to either the supplement plus diet advice or diet advice alone. They will measure changes in blood inflammatory markers, stool calprotectin, lipid levels, pain perception, and quality of life. The goal is to see if this nutritional approach can support symptom management in endometriosis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Fish-derived lipid supplement (BioMarine® Medical Immuno & Neuro Lipids)
What this could lead to
If it works, this could point toward a dietary supplement that helps manage endometriosis symptoms like pain and inflammation, improving quality of life.
What could go wrong
This is a small, early-stage trial with 46 participants, so results may not apply broadly. The supplement may cause digestive side effects, and its benefit over diet alone is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Apr 2024

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female sex. * Age \>18 years and \<55 years. * Diagnosis of endometriosis confirmed by a gynecologist. * Ability and willingness to provide written informed consent. * Ability and willingness to comply with the study procedures, including dietary recommendation Exclusion Criteria: * Pregnancy or lactation. * Menopause or postmenopausal status. * Liver, kidney, or heart disease. * Acute inflammatory conditions, including acute inflammation of the intestines, pancreas, liver, or gallbladder. * Fish allergy or hypersensitivity to any component of the study product. * Epilepsy. * Implanted medical devices or materials, including pacemaker, defibrillator, stent, metal suture in the heart or blood vessel, or implants. * Previous radiotherapy or chemotherapy. * Health condition requiring a specialist diet. * Current use of dietary supplements containing n-3, n-6, or n-9 fatty acids.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease endometriosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometriosis Endometriosis (diagnosis)

Contacts and locations

Locations

  • Warsaw University of Life Sciences

    Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.